Purification Method Development
BIA Separations has extensive experience in purification method development. By incorporating CIM® technology in the purification process, we can develop or co-develop cutting-edge bioseparation technology solutions to purify peptides, oligonuclotides, proteins, DNAs and virus vectors.
Contract Purification
BIA Separations uses its expertise in purification technology to provide cost-effective, high quality, and fast purifications of target biomolecules for the Biotechnology, Pharmaceutical and Diagnostics Industry. The properties of CIM® technology allow us to perform purifications much faster than the traditional particle based separation technologies offered by other companies.ISO 9001 CERTIFED FACILITIES
Our method development and contract purification services follow cGLP and ISO 9001:2000 standards.Prices are quoted based upon the project’s scope. For more information, please contact us.
Contract Research
BIA Separations’ Contract Research Laboratory specializes in HPLC and GC Chromatography and provides analytical method development and validation, analysis of pharmacokinetic study samples, and isolation and identification of drug impurities and metabolites using high-resolution MS and high resolution NMR instruments.The laboratory is specialised in:
- the validation of resins used for industrial chromatography which includes column leachables formed during the production process,
- development of HPLC methods using electrochemical multiarray detectors,
- isolation and identification of drug impurities.
ISO 9001 CERTIFIED FACILITIES
Our method development and contract purification services follow cGLP and ISO 9001:2000 standards.During its inspection, the FDA noted that the lab was GMP compliant and meet all of the requirements as a Control Testing Laboratory.For more information on using our services, please contact us.
